Why the study?
CIC-rearranged sarcoma has an aggressive clinical course and poor prognosis, and no standard treatment has been established.
Do Ewing sarcoma chemotherapy regimens improve disease control in patients with secondary CIC-rearranged sarcoma?
Do Ewing sarcoma chemotherapy regimens improve disease control in patients with secondary CIC-rearranged sarcoma?
Chemotherapy regimens used for Ewing sarcoma, such as ifosfamide and etoposide, may provide disease control in patients with metastatic CIC-rearranged sarcoma.
Answers are grounded in this paper and cite their sources.
May support Ewing regimens for CIC-rearranged sarcoma; hypothesis-generating and requires prospective trials before practice change.
Capicua transcriptional repressor (CIC)‑rearranged sarcoma is an Ewing‑like sarcoma with an aggressive clinical course and poor prognosis. No standard treatment has been established. The present study describes a case of CIC‑rearranged sarcoma with lung metastases developing in a 24‑year‑old woman as a therapy‑associated malignancy following chemotherapy for anaplastic large cell lymphoma at nine years old. This was treated with palliative regimens used for Ewing sarcoma. The patient achieved disease control for one year. Of note, ifosfamide and etoposide (IE), which were used as a second line treatment lead to a partial response. The case described in the present study indicated that treatment with Ewing regimens is a reasonable option for patients with metastatic CIC‑rearranged sarcoma, including those with a second malignant case. Introduction
No takes yet. Share an insight, caveat, or question.
Kimbara et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: